
Joint Juice Dietary Supplements
Between November 2016 and January 2017, multiple class action lawsuits were filed against Joint Juice for allegedly deceptively marketing its line of glucosamine supplements. Specifically, the complaints allege that the supplements will support and nourish cartilage, lubricate joints, and improve joint comfort when, in reality, scientific studies conclude that the ingredients in the products do not provide the advertised benefits.
To learn more and read the complaints, click on the case information below.
- Dent et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-6721, N. D. CA.
- Fishon et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-6980, N. D. CA.
- Lux et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-6703, N. D. CA.
- Ravinsky et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-6704, N. D. CA.
- Sandoval et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-6708, N. D. CA.
- Schupp et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 17-cv-54, N. D. CA.
- Simmons et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-7078, N. D. CA.
- Spencer et al v. Premier Nutrition Corporation f/k/a Joint Juice, Inc., Case No. 16-cv-7097, N. D. CA.
- Taylor et al v. Premier Nutrition Corporation f/k/a/ Joint Juice, Inc., Case No. 16-cv-7097, N. D. CA.
For more information about other class-action lawsuits regarding glucosamine products and TINA.org’s coverage of the products, click here.
Class-Action Tracker
The Latest

PlatinumLED Red Light Therapy
TINA.org sheds light on medical device company’s marketing claims.

Ancestry.com
TINA.org uncovers questionable roots behind this “free” offer.

Everlywell’s Food Sensitivity Tests
These claims to detect intolerances to more than 200 foods are tough to stomach.

CATrends: Made in USA Claims
Lawsuits challenge American-made claims.

Sharkbanz
TINA.org takes a bite out of company’s research.